Syngene International Announces Mixed Financial Results for Q1 FY25

Jul 24 2024 05:45 PM IST
share
Share Via
Syngene International, a leading pharmaceutical company, has reported its financial results for the quarter ending June 2024. The company's stock has been given a 'Hold' call by MarketsMojo. While the operating cash flow has been consistently growing, the profit before and after tax, as well as net sales, have seen a decline. Investors are advised to monitor the company's performance in the upcoming quarters.

Syngene International, a leading pharmaceutical company in the largecap industry, has recently announced its financial results for the quarter ending June 2024. The company’s stock has been given a ‘Hold’ call by MarketsMOJO.

According to the financial report, Syngene Intl. has seen a negative performance in the quarter, with a score of -11 compared to 7 in the previous quarter. However, there are some positive aspects to the company’s financials. The operating cash flow has been consistently growing each year for the past three years, with the highest amount of Rs 1,042.10 crore generated in the last year.


On the other hand, there are some areas that are not performing well for Syngene Intl. The profit before tax less other income (PBT) for the quarter has fallen by -62.2% compared to the average of the previous four quarters. The profit after tax (PAT) has also seen a decline of -60.1% compared to the average of the previous four quarters. The company’s ability to manage interest payments has also deteriorated, with the operating profit to interest ratio being the lowest in the last five quarters.


The net sales for the quarter have also seen a decline, with the company’s near term sales trend being negative. The operating profit and operating profit margin have also decreased, indicating a decline in the company’s efficiency. The earnings per share (EPS) for the quarter have also decreased, showing a decline in profitability and lower earnings for shareholders.


Overall, the financial results for the quarter ending June 2024 for Syngene International show a mix of positive and negative aspects. Investors are advised to hold their stock and monitor the company’s performance in the upcoming quarters.


{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News